SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla informs about business updates

04 Oct 2016 Evaluate

Cipla has submitted a copy of the Notice published on October 04, 2016 in Newspapers informing that the Company intends to apply to the Central Government under section 196 read with Schedule V and other applicable provisions of the Companies Act, 2013 for seeking its approval to the appointment of Umang Vohra as Managing Director of the Company designated as ‘Managing Director and Global Chief Executive Officer’ for a period of five years with effect from September 01, 2016

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1300.80 -5.05 (-0.39%)
24-Apr-2026 13:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.15
Dr. Reddys Lab 1324.00
Cipla 1300.80
Zydus Lifesciences 930.50
Lupin 2285.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×